Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2007-12-31
2009-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Aripiprazole Once Monthly Medications on Changes in Brain Structure and Metabolism
NCT02237417
A Phase 4 Study to Assess the Effects of Aripiprazole Versus Other Atypical Antipsychotics in the Treatment of Schizophrenic Patients With Metabolic Syndrome
NCT00508157
Effectiveness of Aripiprazole Long-acting Injection in Recent Onset and Chronic Schizophrenia Patients
NCT03839251
Study of Alternate Formulation of Aripiprazole in Agitated Patients With Schizophrenic Disorders
NCT00036127
Efficacy & Safety Study of Oral Aripiprazole in Adolescents With Schizophrenia
NCT01149655
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The measurement of weight and lipid profile and fasting blood glucose will be measured at baseline and every 3 months for 1 year.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
observational
patients with schizophrenia who want to change an antipsychotics due to metabolic side effect
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* who signed an informed consent
Exclusion Criteria
* pregnancy or lactation
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Korea Otsuka Pharmaceutical Co., Ltd.
INDUSTRY
Seoul National Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Seoul National Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jong-il Lee, M.D.
Role: STUDY_DIRECTOR
Seoul National Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seoul National Hospital
Seoul, , South Korea
Seoul National Hospital
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MSABLI
Identifier Type: -
Identifier Source: secondary_id
snh002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.